Clinical Trial Update: A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance [Phase 1, Phase 2]

View source ↗

Summary

A randomized, double-blind study evaluating safety, tolerability, and pharmacodynamics of a single IV dose of TD-8954 vs metoclopramide in critically ill patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enteral Feeding Intolerance

Drugs mentioned

• Metoclopramide (metoclopramide)
• TD-8954 (TD-8954)

Snippet

Sponsor: Takeda | Conditions: Enteral Feeding Intolerance | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-14